ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
About ReviR Therapeutics
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs. Its RNA therapeutics treat cancer, rare genetic disorders, and infectious diseases. It also develops an AI-based and computation-empowered platform to discover RNA-targeting therapeutics.
Company Facts
- Headquarters
- Brisbane
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00011_00050
- Funding Stage
- early_stage_venture
- Total Funding
- $54,618,687
- Last Funding Type
- grant
- Last Funding Date
- 2025-01-30
- Website
- revirtx.com
Industries & Categories
Alternative Medicine, Artificial Intelligence (AI), Biotechnology, Genetics, Therapeutics
Social Links
Canonical: https://fsome.com/organization/revir-therapeutics-62514 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.